Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis
Само за регистроване кориснике
2020
Аутори
Milosavljević, FilipBukvić, Nikola
Pavlović, Zorana
Miljević, Čedo
Pešić, Vesna
Molden, Espen
Ingelman-Sundberg, Magnus
Leucht, Stefan
Jukić, Marin
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуИзвор:
European Neuropsychopharmacology, 2020, 40, Supplement 1, S250-S251Издавач:
- Elsevier
Напомена:
- 33rd ECNP Congress, Vienna 2020
Институција/група
PharmacyTY - CONF AU - Milosavljević, Filip AU - Bukvić, Nikola AU - Pavlović, Zorana AU - Miljević, Čedo AU - Pešić, Vesna AU - Molden, Espen AU - Ingelman-Sundberg, Magnus AU - Leucht, Stefan AU - Jukić, Marin PY - 2020 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4761 PB - Elsevier C3 - European Neuropsychopharmacology T1 - Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis VL - 40 IS - Supplement 1 SP - S250 EP - S251 DO - 10.1016/j.euroneuro.2020.09.325 ER -
@conference{ author = "Milosavljević, Filip and Bukvić, Nikola and Pavlović, Zorana and Miljević, Čedo and Pešić, Vesna and Molden, Espen and Ingelman-Sundberg, Magnus and Leucht, Stefan and Jukić, Marin", year = "2020", publisher = "Elsevier", journal = "European Neuropsychopharmacology", title = "Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis", volume = "40", number = "Supplement 1", pages = "S250-S251", doi = "10.1016/j.euroneuro.2020.09.325" }
Milosavljević, F., Bukvić, N., Pavlović, Z., Miljević, Č., Pešić, V., Molden, E., Ingelman-Sundberg, M., Leucht, S.,& Jukić, M.. (2020). Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis. in European Neuropsychopharmacology Elsevier., 40(Supplement 1), S250-S251. https://doi.org/10.1016/j.euroneuro.2020.09.325
Milosavljević F, Bukvić N, Pavlović Z, Miljević Č, Pešić V, Molden E, Ingelman-Sundberg M, Leucht S, Jukić M. Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis. in European Neuropsychopharmacology. 2020;40(Supplement 1):S250-S251. doi:10.1016/j.euroneuro.2020.09.325 .
Milosavljević, Filip, Bukvić, Nikola, Pavlović, Zorana, Miljević, Čedo, Pešić, Vesna, Molden, Espen, Ingelman-Sundberg, Magnus, Leucht, Stefan, Jukić, Marin, "Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis" in European Neuropsychopharmacology, 40, no. Supplement 1 (2020):S250-S251, https://doi.org/10.1016/j.euroneuro.2020.09.325 . .